Paper · 6744667
Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
Bahr GM and 5 others. Clin Exp Immunol, 1984. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells. Papers, record 6744667. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6744667
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphocytes | Major topic |
| Adjuvants, Immunologic | |
| Cells, Cultured | |
| Humans | |
| Immunoglobulins | |
| In Vitro Techniques | |
| Lectins | |
| Stereoisomerism | |
| Thymidine |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 812,088 | Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/812088 | PubMed |
| 2 | 807,619 | Multiple skin testing in leprosy. | J Hyg (Lond) | 1975 | https://conductscience.org/library/papers/807619 | PubMed |
| 3 | 852,928 | Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs. | Int J Pept Protein Res | 1977 | https://conductscience.org/library/papers/852928 | PubMed |
| 4 | 301,172 | The specificity of T-cell helper factor in man. | J Exp Med | 1977 | https://conductscience.org/library/papers/301172 | PubMed |
| 5 | 325,566 | Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/325566 | PubMed |
| 6 | 877,134 | Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. | Proc Soc Exp Biol Med | 1977 | https://conductscience.org/library/papers/877134 | PubMed |
| 7 | 302,770 | Human leucocyte responses in vitro. I. Transformation of purified T lymphocytes with and without addition of partially purified monocytes. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/302770 | PubMed |
| 8 | 562,238 | Nonspecific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine). | Cell Immunol | 1977 | https://conductscience.org/library/papers/562238 | PubMed |
| 9 | 563,773 | In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice. | Cell Immunol | 1978 | https://conductscience.org/library/papers/563773 | PubMed |
| 10 | 413,867 | Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide. | J Immunol | 1978 | https://conductscience.org/library/papers/413867 | PubMed |
1 to 10 of 33
See all 33 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,465,529 | In Commemoration of Dr. Farrokh Modabber: An Iranian Pioneer of Cellular Immunology, and Leishmaniases Vaccine Research in Iran and the World. | Arch Iran Med | 2024 | https://conductscience.org/library/papers/39465529 | PubMed |
| 28,449,603 | Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide. | Int J Immunopathol Pharmacol | 2017 | https://conductscience.org/library/papers/28449603 | PubMed |
| 19,002,881 | In vitro immunization can elicit the expansion of diverse repertoire of B cells from peripheral blood mononuclear cells. | Cytotechnology | 2006 | https://conductscience.org/library/papers/19002881 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6744667
GET https://conductscience.org/api/papers/v1/6744667/references?page=2